Open Access

Cyclin‑dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma

  • Authors:
    • Yupeng Deng
    • Qun Han
    • Shuyu Mei
    • Hailing Li
    • Fan Yang
    • Jun Wang
    • Shuang Ge
    • Xiaotong Jing
    • Hui Xu
    • Tingguo Zhang
  • View Affiliations

  • Published online on: July 25, 2019     https://doi.org/10.3892/ol.2019.10668
  • Pages: 2845-2852
  • Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cyclin‑dependent kinase subunit (CKS) 2 is a member of the CKS family, which plays an important role in the regulation of meiosis and mitosis. Overexpression of CKS2 has been reported in several types of tumors. However, few studies have investigated its role in uterine leiomyosarcoma (ULMS). In the present study, the expression of CKS2 in 38 cases of ULMS and 38 cases of uterine leiomyoma (ULM) was analyzed by immunohistochemistry. Moreover, the functional analysis of CKS2 was performed in ULMS cell lines. A significantly higher expression of CKS2 was found in ULMS tissues than in ULM tissues (P<0.01) and high CKS2 expression was associated with increased tumor size, low progesterone receptor expression and poor prognosis in patients with ULMS. Multivariate Cox regression analysis revealed that CKS2 expression status was an independent predictor of overall survival for ULMS. Furthermore, silencing of CKS2 in ULMS cells inhibited cell proliferation, colony formation, migration and invasion, and resulted in cell cycle arrest. In conclusion, the present study demonstrated that CKS2 may serve as a marker for the differential diagnosis of ULMS and ULM. In addition, it may act as an independent prognostic factor in patients with ULMS, and serve as a novel target for ULMS therapy.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Deng Y, Han Q, Mei S, Li H, Yang F, Wang J, Ge S, Jing X, Xu H, Zhang T, Zhang T, et al: Cyclin‑dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma. Oncol Lett 18: 2845-2852, 2019
APA
Deng, Y., Han, Q., Mei, S., Li, H., Yang, F., Wang, J. ... Zhang, T. (2019). Cyclin‑dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma. Oncology Letters, 18, 2845-2852. https://doi.org/10.3892/ol.2019.10668
MLA
Deng, Y., Han, Q., Mei, S., Li, H., Yang, F., Wang, J., Ge, S., Jing, X., Xu, H., Zhang, T."Cyclin‑dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma". Oncology Letters 18.3 (2019): 2845-2852.
Chicago
Deng, Y., Han, Q., Mei, S., Li, H., Yang, F., Wang, J., Ge, S., Jing, X., Xu, H., Zhang, T."Cyclin‑dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma". Oncology Letters 18, no. 3 (2019): 2845-2852. https://doi.org/10.3892/ol.2019.10668